Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7.

Tedla N, Bandeira-Melo C, Tassinari P, Sloane DE, Samplaski M, Cosman D, Borges L, Weller PF, Arm JP.

Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1174-9. Epub 2003 Jan 14.

2.

Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition.

Sloane DE, Tedla N, Awoniyi M, Macglashan DW Jr, Borges L, Austen KF, Arm JP.

Blood. 2004 Nov 1;104(9):2832-9. Epub 2004 Jul 8.

3.

2B4 (CD244) is expressed and functional on human eosinophils.

Munitz A, Bachelet I, Fraenkel S, Katz G, Mandelboim O, Simon HU, Moretta L, Colonna M, Levi-Schaffer F.

J Immunol. 2005 Jan 1;174(1):110-8.

4.

IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling.

Bandeira-Melo C, Sugiyama K, Woods LJ, Phoofolo M, Center DM, Cruikshank WW, Weller PF.

J Immunol. 2002 May 1;168(9):4756-63.

5.
6.

The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils.

Munitz A, Bachelet I, Eliashar R, Moretta A, Moretta L, Levi-Schaffer F.

Blood. 2006 Mar 1;107(5):1996-2003. Epub 2005 Oct 27. Erratum in: Blood. 2006 Apr 1;107(7):2612.

7.
8.

The co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium.

Tedla N, Gibson K, McNeil HP, Cosman D, Borges L, Arm JP.

Am J Pathol. 2002 Feb;160(2):425-31.

9.
10.

EliCell assay for the detection of released cytokines from eosinophils.

Bandeira-Melo C, Perez SA, Melo RC, Ghiran I, Weller PF.

J Immunol Methods. 2003 May 1;276(1-2):227-37.

PMID:
12738376
11.

Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils.

Bandeira-Melo C, Hall JC, Penrose JF, Weller PF.

J Allergy Clin Immunol. 2002 Jun;109(6):975-9.

PMID:
12063527
12.
13.
14.

Interleukin-12 inhibits eosinophil degranulation and migration but does not promote eosinophil apoptosis.

Davoine F, Ferland C, Chakir J, Lee JE, Adamko DJ, Moqbel R, Laviolette M.

Int Arch Allergy Immunol. 2006;140(4):277-84. Epub 2006 May 20.

PMID:
16735797
15.

Release of granule proteins from human eosinophils stimulated with mast-cell mediators.

Takafuji S, Tadokoro K, Ito K, Nakagawa T.

Allergy. 1998 Oct;53(10):951-6.

16.

Inhibitory receptor gp49B regulates eosinophil infiltration during allergic inflammation.

Norris HH, Peterson ME, Stebbins CC, McConchie BW, Bundoc VG, Trivedi S, Hodges MG, Anthony RM, Urban JF Jr, Long EO, Keane-Myers AM.

J Leukoc Biol. 2007 Dec;82(6):1531-41. Epub 2007 Aug 30.

PMID:
17761953
17.

IL-3 induces B7.2 (CD86) expression and costimulatory activity in human eosinophils.

Celestin J, Rotschke O, Falk K, Ramesh N, Jabara H, Strominger J, Geha RS.

J Immunol. 2001 Dec 1;167(11):6097-104.

18.
19.
20.

Delineation of the region in the glycoprotein VI tail required for association with the Fc receptor gamma-chain.

Bori-Sanz T, Inoue KS, Berndt MC, Watson SP, Tulasne D.

J Biol Chem. 2003 Sep 19;278(38):35914-22. Epub 2003 Jul 7.

Supplemental Content

Support Center